# ALX Oncology Holdings Inc: Form DEF 14A, filed Apr 22, 2024

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: DEF 14A
- Filed: 2024-04-22
- Accepted by EDGAR: Apr 22, 2024, 20:01 ET
- Period: 2024-06-12
- Accession: 0000950170-24-046410
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000095017024046410/alxo_def_14a_2024_proxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000095017024046410/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000095017024046410/alxo_def_14a_2024_proxy.htm

Filed Apr 22, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-046410. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.